Pretreatment FDG-PET Biomarkers Predict Regional and Distant Failure but Not Local Recurrence Following Modern Use of Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
Clinical Lung Cancer · 2026-12 · 27 (10) · 16-24
DOI: 10.1016/j.cllc.2026.09.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lung Cancer, 2026-12. Verfasst von Dasantha Jayamanne und 13 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology, Northern Sydney Local Health District Executive, Royal North Shore Hospital, Sydney, New South Wales, Australia; Sydney Universit…. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Radiation Oncology, Northern Sydney Local Health District Executive, Royal North Shore Hospital, Sydney, New South Wales, Australia; Sydney University Medical Faculty, Sydney, New South Wales, Australia.
- Radiation Oncology, Northern Sydney Local Health District Executive, Royal North Shore Hospital, Sydney, New South Wales, Australia; Sydney University Medical Faculty, Sydney, New South Wales, Australia. Electronic addr…
- Sydney University Medical Faculty, Sydney, New South Wales, Australia; Nuclear Medicine, Northern Sydney Local Health District Executive, Royal North Shore Hospital, Sydney, New South Wales, Australia.
- Research Directorate, Northern Sydney Local Health District Executive, Royal North Shore Hospital, Sydney, New South Wales, Australia.
- Sydney University Medical Faculty, Sydney, New South Wales, Australia; Medical Oncology, Northern Sydney Local Health District Executive, Royal North Shore Hospital, Sydney, New South Wales, Australia.
- Sydney University Medical Faculty, Sydney, New South Wales, Australia; Respiratory Medicine, Northern Sydney Local Health District Executive, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Zitieren
APA
Jayamanne, D., Chan, J., Mohan, R., Dave, S., Ayesa, S., Schembri, G., Venkatesha, V., Pavlakis, N., Itchins, M., Davis, A., Harris, B., Hibbert, M., Don, G., & Clarke, S. (2026). Pretreatment FDG-PET Biomarkers Predict Regional and Distant Failure but Not Local Recurrence Following Modern Use of Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer. Clinical Lung Cancer, 27(10), 16-24. https://doi.org/10.1016/j.cllc.2026.09.009
Vancouver
Jayamanne D, Chan J, Mohan R, Dave S, Ayesa S, Schembri G, et al. Pretreatment FDG-PET Biomarkers Predict Regional and Distant Failure but Not Local Recurrence Following Modern Use of Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer. Clinical Lung Cancer. 2026;27(10):16-24. doi:10.1016/j.cllc.2026.09.009
BibTeX
@article{Jayamanne2026,
author = {Jayamanne, Dasantha and Chan, Joseph and Mohan, Riche and Dave, Sameer and Ayesa, Sally and Schembri, Geoff and Venkatesha, Venkatesha and Pavlakis, Nick and Itchins, Malinda and Davis, Alex and Harris, Ben and Hibbert, Michael and Don, Garrick and Clarke, Stephen},
title = {Pretreatment FDG-PET Biomarkers Predict Regional and Distant Failure but Not Local Recurrence Following Modern Use of Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer},
journal = {Clinical Lung Cancer},
year = {2026},
volume = {27},
number = {10},
pages = {16--24},
doi = {10.1016/j.cllc.2026.09.009}
}
EUVIMED